Neuralink Corporation is an American neurotechnology company founded by Elon Musk and others in 2016. The company develops brain-computer interfaces (BCIs) with the stated goal of helping people with severe neurological conditions and ultimately achieving symbiosis between human brains and artificial intelligence. Headquartered in Fremont, California, Neuralink has developed a device called the “Link,” a brain implant that connects to thousands of microscopic threads that interface directly with neurons. The company’s primary technology involves a surgical robot that precisely inserts flexible electrode threads into the brain. Each thread is thinner than a human hair and contains multiple electrodes that can detect neural signals. The device is designed to be upgradeable and can potentially be removed if needed. In 2023, Neuralink received FDA approval to conduct human clinical trials of its brain implant technology. The company has previously conducted animal trials, including demonstrations with monkeys playing Pong using only their thoughts. Neuralink has raised significant funding through multiple investment rounds and has assembled a team of leading researchers in neuroscience, robotics, and engineering. The company faces competition from other neurotechnology firms and has attracted both praise for its innovative approach and criticism regarding animal testing practices and the feasibility of its long-term goals.